Is there a more punch-worthy douche?
- Thread starter Locutus
- Start date
’Pharma Bro’ in the hole for alleged phone use while in prison
Associated Press
Published:
April 2, 2019
Updated:
April 2, 2019 6:53 PM EDT
In this Dec. 17, 2015, file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York, after being taken into custody following a securities probe. Pharmaceutical honcho Shkreli has been banished to solitary confinement amid allegations he was running his drug company from federal prison using a contraband smartphone, a person familiar with the matter told The Associated Press.Craig Ruttle / AP
NEW YORK — Pharmaceutical honcho Martin Shkreli has been banished to solitary confinement amid allegations he was running his drug company from federal prison using a contraband smartphone, a person familiar with the matter told The Associated Press.
Shkreli was moved to solitary confinement at the Fort Dix, New Jersey, facility on March 7 and is likely to remain there while his alleged conduct is being investigated, the person said. The person wasn’t authorized to discuss the matter publicly and spoke on condition of anonymity.
The U.S. Bureau of Prisons told the AP on March 8 that it was investigating whether Shkreli, known as the “Pharma Bro,” violated prison rules forbidding inmates from conducting business and possessing cellphones.
That inquiry hasn’t resulted in any charges within the agency’s inmate discipline program, the person said, indicating that the matter may have been referred to federal prosecutors for potential criminal prosecution.
Shkreli’s lawyer, Benjamin Brafman, declined to comment.
Story continues below
This advertisement has not loaded yet,
but your article continues below.
The Bureau of Prisons said it does not release information on an individual inmate’s conditions of confinement.
“The matter you reference is under investigation,” the agency said in a statement. “When there are allegations of misconduct, they are thoroughly investigated and appropriate action is taken if allegations are sustained.”
The U.S. Attorney’s Office in Brooklyn, which prosecuted Shkreli’s securities fraud case, declined to comment. The U.S. Attorney’s Office in New Jersey also declined to comment.
Shkreli’s move to solitary confinement was first reported by Forbes .
Shkreli, 36, is serving a seven-year sentence at a low-security prison complex about 40 miles (65 kilometres) from Philadelphia. He was convicted in August 2017 of lying to investors in two failed hedge funds and cheating them out of millions.
The Wall Street Journal reported last month that Shkreli has used a cellphone to call the shots at his drug company, Phoenixus AG, posting regularly to social media and even firing the company’s chief executive.
The punishment for inmates caught with cellphones depends on how the case is handled.
If it’s prosecuted in court, a conviction could tack on up to an extra year of prison time. Within the inmate discipline program, having a cellphone is considered a “greatest severity level” offence and carries sanctions ranging from loss to privileges to up to a year in solitary confinement.
In Shkreli’s case, he could face more punishment if he’s also found to have conducted business while locked up.
Other than the alleged cellphone flap, Shkreli has been pretty well behaved. His only other violations were for refusing an order and being absent from an assignment in May 2018, inmate disciplinary records show.
Shkreli’s securities fraud case stemmed from his role managing MSMB Capital Management and MSMB Healthcare between 2009 and 2014. It was unrelated to the 2015 furor he caused when he raised the price by more than 5,000% of a drug used to treat an infection that occurs in some AIDS, malaria and cancer patients.
http://torontosun.com/news/world/pharma-bro-in-the-hole-for-alleged-phone-use-while-in-prison
Associated Press
Published:
April 2, 2019
Updated:
April 2, 2019 6:53 PM EDT
In this Dec. 17, 2015, file photo, Martin Shkreli, the former hedge fund manager under fire for buying a pharmaceutical company and ratcheting up the price of a life-saving drug, is escorted by law enforcement agents in New York, after being taken into custody following a securities probe. Pharmaceutical honcho Shkreli has been banished to solitary confinement amid allegations he was running his drug company from federal prison using a contraband smartphone, a person familiar with the matter told The Associated Press.Craig Ruttle / AP
NEW YORK — Pharmaceutical honcho Martin Shkreli has been banished to solitary confinement amid allegations he was running his drug company from federal prison using a contraband smartphone, a person familiar with the matter told The Associated Press.
Shkreli was moved to solitary confinement at the Fort Dix, New Jersey, facility on March 7 and is likely to remain there while his alleged conduct is being investigated, the person said. The person wasn’t authorized to discuss the matter publicly and spoke on condition of anonymity.
The U.S. Bureau of Prisons told the AP on March 8 that it was investigating whether Shkreli, known as the “Pharma Bro,” violated prison rules forbidding inmates from conducting business and possessing cellphones.
That inquiry hasn’t resulted in any charges within the agency’s inmate discipline program, the person said, indicating that the matter may have been referred to federal prosecutors for potential criminal prosecution.
Shkreli’s lawyer, Benjamin Brafman, declined to comment.
Story continues below
This advertisement has not loaded yet,
but your article continues below.
The Bureau of Prisons said it does not release information on an individual inmate’s conditions of confinement.
“The matter you reference is under investigation,” the agency said in a statement. “When there are allegations of misconduct, they are thoroughly investigated and appropriate action is taken if allegations are sustained.”
The U.S. Attorney’s Office in Brooklyn, which prosecuted Shkreli’s securities fraud case, declined to comment. The U.S. Attorney’s Office in New Jersey also declined to comment.
Shkreli’s move to solitary confinement was first reported by Forbes .
Shkreli, 36, is serving a seven-year sentence at a low-security prison complex about 40 miles (65 kilometres) from Philadelphia. He was convicted in August 2017 of lying to investors in two failed hedge funds and cheating them out of millions.
The Wall Street Journal reported last month that Shkreli has used a cellphone to call the shots at his drug company, Phoenixus AG, posting regularly to social media and even firing the company’s chief executive.
The punishment for inmates caught with cellphones depends on how the case is handled.
If it’s prosecuted in court, a conviction could tack on up to an extra year of prison time. Within the inmate discipline program, having a cellphone is considered a “greatest severity level” offence and carries sanctions ranging from loss to privileges to up to a year in solitary confinement.
In Shkreli’s case, he could face more punishment if he’s also found to have conducted business while locked up.
Other than the alleged cellphone flap, Shkreli has been pretty well behaved. His only other violations were for refusing an order and being absent from an assignment in May 2018, inmate disciplinary records show.
Shkreli’s securities fraud case stemmed from his role managing MSMB Capital Management and MSMB Healthcare between 2009 and 2014. It was unrelated to the 2015 furor he caused when he raised the price by more than 5,000% of a drug used to treat an infection that occurs in some AIDS, malaria and cancer patients.
http://torontosun.com/news/world/pharma-bro-in-the-hole-for-alleged-phone-use-while-in-prison
’Pharma Bro’ Martin Shkreli sues over ouster from company
Associated Press
Published:
May 31, 2019
Updated:
May 31, 2019 5:59 PM EDT
In this Aug. 4, 2017 file photo, Martin Shkreli arrives at federal court in New York, for the fifth day of deliberations at his securities fraud trial. (AP Photo/Seth Wenig, File)
NEW YORK — Imprisoned pharmaceutical entrepreneur Martin Shkreli sued three executives at a company he started Friday, saying they illegally ousted him and defrauded the company of millions of dollars.
The lawsuit was filed Friday in Manhattan federal court. It seeks unspecified damages.
Shkreli, 36, was dubbed the Pharma Bro and is perhaps best known for boosting the price of a life-saving drug by more than 5,000% and trolling his critics on social media while he worked at Retrophin.
He was convicted in August 2017 of fraud related to his handling of hedge fund investments and Retrophin stock but brashly predicted he’d never go to prison. Shkreli is serving a seven-year prison sentence.
Recently, he’s spent time in solitary confinement while the U.S. Bureau of Prisons investigated whether he violated rules forbidding inmates from conducting business and possessing cellphones.
Martin Shkreli moved to low-security prison in New Jersey
Martin Shkreli sentenced to 7 years in prison
Martin Shkreli’s ex-lawyer found guilty of financial fraud
In his lawsuit, Shkreli alleged that he was “unceremoniously and illegally ousted” from the company he started by executives who were “driven by their egos, jealousy and greed.”
The lawsuit said Shkreli was fraudulently induced to negotiate the terms of departure from the company before he was tricked into signing a fraudulent document, resigning voluntarily from the company and giving up his rights as the chief executive and founder.
He alleged through the lawsuit that those who ousted him paid themselves over $35 million.
The company declined through a spokesman to comment.
http://torontosun.com/news/world/pharma-bro-martin-shkreli-sues-over-ouster-from-company
Associated Press
Published:
May 31, 2019
Updated:
May 31, 2019 5:59 PM EDT
In this Aug. 4, 2017 file photo, Martin Shkreli arrives at federal court in New York, for the fifth day of deliberations at his securities fraud trial. (AP Photo/Seth Wenig, File)
NEW YORK — Imprisoned pharmaceutical entrepreneur Martin Shkreli sued three executives at a company he started Friday, saying they illegally ousted him and defrauded the company of millions of dollars.
The lawsuit was filed Friday in Manhattan federal court. It seeks unspecified damages.
Shkreli, 36, was dubbed the Pharma Bro and is perhaps best known for boosting the price of a life-saving drug by more than 5,000% and trolling his critics on social media while he worked at Retrophin.
He was convicted in August 2017 of fraud related to his handling of hedge fund investments and Retrophin stock but brashly predicted he’d never go to prison. Shkreli is serving a seven-year prison sentence.
Recently, he’s spent time in solitary confinement while the U.S. Bureau of Prisons investigated whether he violated rules forbidding inmates from conducting business and possessing cellphones.
Martin Shkreli moved to low-security prison in New Jersey
Martin Shkreli sentenced to 7 years in prison
Martin Shkreli’s ex-lawyer found guilty of financial fraud
In his lawsuit, Shkreli alleged that he was “unceremoniously and illegally ousted” from the company he started by executives who were “driven by their egos, jealousy and greed.”
The lawsuit said Shkreli was fraudulently induced to negotiate the terms of departure from the company before he was tricked into signing a fraudulent document, resigning voluntarily from the company and giving up his rights as the chief executive and founder.
He alleged through the lawsuit that those who ousted him paid themselves over $35 million.
The company declined through a spokesman to comment.
http://torontosun.com/news/world/pharma-bro-martin-shkreli-sues-over-ouster-from-company
New York, FTC sue 'Pharma Bro' Shkreli, others over Daraprim price hikes
Reuters
Published:
January 27, 2020
Updated:
January 27, 2020 4:53 PM EST
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017. (REUTERS/Carlo Allegri/File Photo/File Photo)
WASHINGTON — Martin Shkreli, the “Pharma Bro” in prison for defrauding investors, faces a lawsuit filed by the Federal Trade Commission and New York Attorney General’s office for a scheme to preserve his monopoly for the drug Daraprim, which has seen gigantic price increases.
The lawsuit accuses a company that Shkreli once ran of buying the rights to Daraprim, which is used to treat toxoplasmosis, and quickly raising the price from $17.50 per tablet to $750 while also taking steps to ensure that there would not be a generic version of the medicine. The company named is Vyera Pharmaceuticals, formerly Turing Pharmaceuticals, which was headed by Shkreli.
For example, the FTC alleges that the company restricted distribution of the medicine to ensure that generic drug makers could not get the samples that they would need to make their own version of the drug. The company also prevented potential competitors from buying one of the ingredients needed for the medicine, the FTC said.
A spokeswoman for Vyera and a lawyer for Shkreli did not immediately respond to a request for comment.
Shkreli became notorious as “Pharma Bro” when he raised the price of the anti-parasitic drug Daraprim by more than 5,000% in 2015 as chief executive of Turing Pharmaceuticals.
The U.S. Supreme Court said in November that Shkreli must remain in prison, rejecting his effort to overturn his conviction and seven-year sentence for securities fraud and conspiracy.
'Pharma Bro' Martin Shkreli loses appeal of conviction, sentence
’Pharma Bro’ Martin Shkreli sues over ouster from company
The justices refused to hear Shkreli’s appeal of his August 2017 conviction and $7.36 million forfeiture for cheating investors in two hedge funds he founded, and trying to prop up the stock price of biotechnology company Retrophin Inc, which he once ran.
http://torontosun.com/news/world/ne...-bro-shkreli-others-over-daraprim-price-hikes
Reuters
Published:
January 27, 2020
Updated:
January 27, 2020 4:53 PM EST
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017. (REUTERS/Carlo Allegri/File Photo/File Photo)
WASHINGTON — Martin Shkreli, the “Pharma Bro” in prison for defrauding investors, faces a lawsuit filed by the Federal Trade Commission and New York Attorney General’s office for a scheme to preserve his monopoly for the drug Daraprim, which has seen gigantic price increases.
The lawsuit accuses a company that Shkreli once ran of buying the rights to Daraprim, which is used to treat toxoplasmosis, and quickly raising the price from $17.50 per tablet to $750 while also taking steps to ensure that there would not be a generic version of the medicine. The company named is Vyera Pharmaceuticals, formerly Turing Pharmaceuticals, which was headed by Shkreli.
For example, the FTC alleges that the company restricted distribution of the medicine to ensure that generic drug makers could not get the samples that they would need to make their own version of the drug. The company also prevented potential competitors from buying one of the ingredients needed for the medicine, the FTC said.
A spokeswoman for Vyera and a lawyer for Shkreli did not immediately respond to a request for comment.
Shkreli became notorious as “Pharma Bro” when he raised the price of the anti-parasitic drug Daraprim by more than 5,000% in 2015 as chief executive of Turing Pharmaceuticals.
The U.S. Supreme Court said in November that Shkreli must remain in prison, rejecting his effort to overturn his conviction and seven-year sentence for securities fraud and conspiracy.
'Pharma Bro' Martin Shkreli loses appeal of conviction, sentence
’Pharma Bro’ Martin Shkreli sues over ouster from company
The justices refused to hear Shkreli’s appeal of his August 2017 conviction and $7.36 million forfeiture for cheating investors in two hedge funds he founded, and trying to prop up the stock price of biotechnology company Retrophin Inc, which he once ran.
http://torontosun.com/news/world/ne...-bro-shkreli-others-over-daraprim-price-hikes
That's only a 4300% markup. There've been worse. I saw one that was about 8000%. Can't remember the med, though.
HERE IS A CANDIDATE for "CREEP OF THE MONTH CLUB"!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Here is an article illustrating why our govt books will never be balanced as long as LIE-beral minded goofs are in charge!! With some comments of my own in brackets):
Ex-Montreal mayor can keep $268K severance despite fraud conviction
From Canadian Press
Published: January 20, 2020/ Updated: January 20, 2020 5:16 PM EST
Filed Under: Toronto SUN/ News/ Crime
MONTREAL — Disgraced former Montreal mayor Michael Applebaum can keep the $268,000 he received from the city after resigning from office, despite a conviction for fraud against the government, Quebec Superior Court ruled Monday.
Applebaum is legally entitled to the taxpayer cash because new rules punishing elected officials convicted of crimes went into effect after he broke the law and received his severance package, Justice Serge Gaudet said. The judge added that nothing in the law stipulates the new rules apply retroactively.
(That is all very well - but FRAUDSTER AN BE SUED for the cost of their crimes sp WHY IS THIS GUY NOT BEING PLUCKED like a chicken?????????)
Montreal Mayor Valerie Plante said she was disappointed with the ruling because it sent a signal that politicians can break the law and still get paid. She said the city’s lawyers will analyze the decision to see whether other legal avenues to recoup the money are possible.
Applebaum’s crimes occurred during a period in the city’s history when there was “a lot of corruption and collusion,” Plante told reporters Monday. As a result, she added, Montrealers have become cynical towards municipal politics.
(Yes - in the last ten years Quebec has become NOTORIOUS for its corruption!! At one point councillors in one Montreal suburb actually requested that senior govt take over from them - and supervise them - WITH THE PROVISO that even though others would be making ALL THE DECISIONS for local govt- the councillors WOULD GET TO KEEP BEING PAID IN FULL!!!!!!!!!!!!!!!!!!!!!!)
(Senior gvot declined the offer and suggested that if the councillors really felt they could not do their jobs properly and honestly - they should RESIGN!! Naturally there WERE NO TAKERS for the retirement line!!!!!!!!!!!!!!!!!!!!!!!!!!!)
“If someone is convicted of fraud I think the message to send is that we will fight to get this money back,” she said.
(Uh huh- and let us hope that Our idiot Boy and his loser LIE-berals ARE FIRED from their minority govt BEFORE the statute of limitations runs out on Lavalin!!!)
Applebaum, who was first elected to council in 1994, became the city’s interim mayor in 2012 on a promise to clean up the city’s scandal-plagued politics. He replaced mayor Gerald Tremblay, who resigned after his administration was accused of corruption by witnesses at a public inquiry.
Applebaum was forced to resign in 2013 when he was arrested on corruption charges. He was convicted in January 2017 of fraud against the government, conspiracy to commit fraud, breach of trust and conspiracy to commit breach of trust. The ex-mayor was sentenced to one year in jail.
(IN the private sector - being convicted of defrauding your boss MEANS NO PENSION OR SEVERANCE PAY FOR YOU!!!!!!!!!!!!!!!!!!!!!!!)
The Crown alleged Applebaum accepted cash through a former aide between 2007 and 2010 in return for favours given to local real estate developers and engineering firms.
As a consequence of the corruption in Montreal and in other Quebec cities, the provincial government changed a law governing municipal politicians, in 2016 and again in 2018. The new rules forced elected officials to reimburse so-called departing and transition allowances if they were convicted of certain crimes.
One month after he resigned in 2013, Applebaum received $108,204 as a departing allowance and another $159,719 as a transition payment, designed to help politicians transition to a new career.
Gaudet ruled that Applebaum’s actions took place before the consequences of those actions were entered into law, despite the fact he was convicted after the first modification of the law went into force.
NOT RELEVANT!! Traditional FRAUD LAW DEMANDS THAT RESTITUTION MUST BE MADE - whenever possible and this goof HAS CASH and thus NEEDS TO BE SUED TO RECOVER DAMAGES!!!!!!!!!!!!!!!!)
Applebaum’s lawyer, Anamaria Natalia Manole, said neither her client’s morality nor his criminal behaviour were on trial.
(Isnt it ODD that the Law Society can ATTACK a lawyer in New Brunswick who was running for election and stated on a radio talk show - to the effect that LIE-beral hug a thug judges were weakeningthe legal system and endangering the public - and that lawyer GOT DISCIPLINED “for bringing the practice of law into dis-repute!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
(Is this former mayor not guilty of bringing POLITICIANS into “disrepute”!!!!!!!)
“This was a matter of law,” she said in an interview. “This isn’t a criminal trial, it was a civil case. The law had to be applied and it was applied.”
Attempts to reach Applebaum for comment were unsuccessful.
(And NO WONDER - if I was him I would be paying for an UNLISTED NUMBER AND CALL SCREENING - AND FOR LARGE FENCES AROUND MY RESIDENCE - to protect against ENRAGED VOTERS!!!!!!!!!!!!!!!!!!!!!!!)
How about we talk about that punch worthy douche Cuomo.................................
and his GORMLESS CABAL of New York state legislators............................................
who have such a LIMITED UNDERSTANDING OF CAUSE AND EFFECT..........................
where crime and criminals are concerned!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
Here is an article illustrating the worst sort of LIE-beral virtue signalling!! With some comments of my own in brackets):
No-bail law boosting crime, but NY leaders still putting off any action
By New York Post Editorial Board
Published March 3, 2020 | 6:31pm
How ironic: Gov. Andrew Cuomo says he’ll hold up the budget unless it fixes the bail-reform law. Last year, he vowed not to OK it unless it included the flawed law.
At least the crime surge sparked by the reform (or public outrage over it) got him to see his mistakes. NYPD stats released Monday show a 20 percent jump in serious crimes over the first two months of the year, including robberies (up 35 percent) and car thefts (64 percent).
(And some LIE-berals WONDER why people want to carry GUNS??????????????)
Yet Assembly Speaker Carl Heastie wants New Yorkers to suffer still more crime before he’ll consider fixes. He pooh-poohed January’s crime uptick, saying it was too early to call it a “trend,” but there’s no sign even two months of data are enough for him.
If Heastie wants more crime, he’ll get it: Monday, a judge freed serial subway scam-mer Charles Barry, after he was nabbed for allegedly swiping cash — his 142nd career arrest and his seventh get-out-of-jail-free card in two months. Want to bet what a guy with 142 arrests does next?
(Yes- LIE-berals have made an amazing mess of our legal system - it costs to much to simply jail incorrigible criminals for life - and LIE-berals refuse to use lower cost and low tech solutions like caning to punish defiant trouble makers!!!!!!!!!!!!!!!!!!!!!)
see also: Cuomo could make bail reform changes in state budget
(The Cdn version of bail “reform” as advocated by Toronto mayor Jackass John Tory involves simply turning accused criminals loose - in hope they will show up in a year or two for their trials - because thanks to damned LIE-berals - getting caught red handed and held in pre- trial custody means you get credit FOR THREE TIMES whatever time you spent in jail pre-trial!! In LIE-beral Crazy Land - holding vicious criminals without bail means THEY GET OUT EVEN FASTER and maybe Cuomo wants try something similar to Jackass John Tory!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
On Friday, a judge again set Tiffany Harris free. She’d already gotten out twice after arrests for other alleged violent crimes, as a result of the reform.
And that was a day after Mark Nelson, a registered sex offender, was set loose in Orange County after being hauled in for trespassing outside a nursery school.
(Oh isnt that nice- a sex offender is prowling around schools?? How will LIE-berals resolve that one?? By arming kiddies - and that suggestion is not so crazy as it sounds - some poor guy in Chicago took his little boy and 3 year old girl into a McDonalds bathroom and while he was distracted - assisting the boy- his little girl was abducted and RAPED!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
(Yes- the attacker was an illegal immigrant with multiple deportations behind him and he just keeps coming back to commit other crimes and of course Chicago is a Sanctuary City so local cops had him in jail on other stuff and turned him loose on bail - WITHOUT Bothering to respond to the ICE WARRANT for deportation and that is when the little girl was abused and her family life DESTROYED!!!!!!!!!!!!!!!)
(THE REAL INSANITY OF THIS SITUATION is that after the guy was arrested and charged for attacking the girl - the suddenly publicity shy judge chose to HOLD THE GUY WITHOUT BAIL!! The guy was DEEPLY OFFENDED BY THAT - WHINING “BUT IT IS ONLY MY FIRST SEX CHARGE”!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!)
Thanks to Heastie, the state won’t jam up the revolving door before April 1; even then, any fixes will be done secretly, with no public oversight, as part of a budget deal.
(No public oversight?? Oh that is CLASSIC LIE-beral style!!!!!!!!!!!!!!!!!!!!!!!!!!)
Cuomo says this year, unlike 2019, he’ll hold a “public” meeting with DAs, police and others. Fine. But he admits pols up for re-election are “afraid” and “don’t want to take a position” — which sounds like a recipe for getting it wrong again.
(IT is also a classic illustration WE PAY POLITICIANS TOO MUCH - since they are so DESPERATE to hang onto the job that they are willing to pay any cowardly humiliating price!!!!!!!!!!)
New Yorkers are stuck hoping Cuomo can sway Heastie, trusting the deal will make the right fixes — and praying they’re not victims of avoidable crimes before then.
(Good luck with that!! Anything LIE-berals get right WILL BE BY ACCIDENT!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
'Most hated man in the world' Pharma Bro finds love with journalist
A former journalist is revealing for the first time how she fell head over heels in love with widely despised ‘Pharma Bro’ Martin Shkreli.
Yep, definitely the right wing's hero.'Most hated man in the world' Pharma Bro finds love with journalist
A former journalist is revealing for the first time how she fell head over heels in love with widely despised ‘Pharma Bro’ Martin Shkreli.torontosun.com
'DUMPED ME THROUGH HIS LAWYERS': Pharma Bro's foiled fan girl looking for new love
There will be no golden sunsets for ‘Pharma Bro’ and the reporter who ditched her husband for the man once called the “most hated” on Earth.
U.S. judge rejects Pharma Bro's bid for compassionate release from prison
NEW YORK — A federal judge rejected former pharmaceutical executive Martin Shkreli’s request to be freed from prison, rejecting his claim that his…
I hope the judge said "Take a pill. You can afford it."U.S. judge rejects Pharma Bro's bid for compassionate release from prison
NEW YORK — A federal judge rejected former pharmaceutical executive Martin Shkreli’s request to be freed from prison, rejecting his claim that his…
U.S. sells 'Pharma Bro' Shkreli's unique Wu-Tang Clan album
Author of the article:Reuters
Reuters
Jonathan Stempel
Publishing date:Jul 27, 2021 • 9 hours ago • 1 minute read • Join the conversation
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017.
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017. PHOTO BY CARLO ALLEGRI /REUTERS
Article content
NEW YORK — The U.S. government said it sold imprisoned drug company executive Martin Shkreli’s one-of-a-kind album by Wu-Tang Clan to pay off the $7.36 million he was ordered to forfeit after being convicted of fraud.
Advertisement
STORY CONTINUES BELOW
Article content
In a letter to U.S. District Judge Kiyo Matsumoto, who oversaw Shkreli’s 2017 trial in Brooklyn, prosecutors said the forfeiture amount has been fully satisfied following the sale of the album “Once Upon a Time in Shaolin” and other asset sales.
The sale price and buyer were not disclosed because of a confidentiality provision in the contract, prosecutors said.
Shkreli, 38, paid $2 million for Wu-Tang Clan’s only copy of “Shaolin” at an auction by the hip-hop group.
He later bragged he did not plan to listen to the album, and purchased it to “keep it from the people.”
Benjamin Brafman, a lawyer for Shkreli, in an email said he was pleased the forfeiture obligation was satisfied, and that the album’s sale price was “substantially more” than what Shkreli paid.
Advertisement
STORY CONTINUES BELOW
Article content
Nicknamed “Pharma Bro,” Shkreli remains widely vilified for hiking the price of Daraprim, which treated a potentially fatal infection, by more than 4,000% overnight when he led Turing Pharmaceuticals, now known as Phoenixus AG.
He has served more than half of a seven-year prison sentence for cheating investors in two hedge funds and trying to prop up the stock price of another drug company he led, Retrophin Inc. His release date is Oct. 11, 2022, prison records show.
Prosecutors said they still possess two other Shkreli assets, a Phoenixus stake and a Pablo Picasso engraving, that could be applied toward a $2.6 million judgment against him in a separate Manhattan civil case.
Brianne Murphy, a lawyer for Shkreli in the Manhattan case, declined to comment.
In January, Matsumoto rejected Shkreli’s request to be freed from prison, rejecting his claim that his deteriorating mental health justified “compassionate” release.
torontosun.com
Author of the article:Reuters
Reuters
Jonathan Stempel
Publishing date:Jul 27, 2021 • 9 hours ago • 1 minute read • Join the conversation
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017.
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud, in the Brooklyn borough of New York City, U.S., August 4, 2017. PHOTO BY CARLO ALLEGRI /REUTERS
Article content
NEW YORK — The U.S. government said it sold imprisoned drug company executive Martin Shkreli’s one-of-a-kind album by Wu-Tang Clan to pay off the $7.36 million he was ordered to forfeit after being convicted of fraud.
Advertisement
STORY CONTINUES BELOW
Article content
In a letter to U.S. District Judge Kiyo Matsumoto, who oversaw Shkreli’s 2017 trial in Brooklyn, prosecutors said the forfeiture amount has been fully satisfied following the sale of the album “Once Upon a Time in Shaolin” and other asset sales.
The sale price and buyer were not disclosed because of a confidentiality provision in the contract, prosecutors said.
Shkreli, 38, paid $2 million for Wu-Tang Clan’s only copy of “Shaolin” at an auction by the hip-hop group.
He later bragged he did not plan to listen to the album, and purchased it to “keep it from the people.”
Benjamin Brafman, a lawyer for Shkreli, in an email said he was pleased the forfeiture obligation was satisfied, and that the album’s sale price was “substantially more” than what Shkreli paid.
Advertisement
STORY CONTINUES BELOW
Article content
Nicknamed “Pharma Bro,” Shkreli remains widely vilified for hiking the price of Daraprim, which treated a potentially fatal infection, by more than 4,000% overnight when he led Turing Pharmaceuticals, now known as Phoenixus AG.
He has served more than half of a seven-year prison sentence for cheating investors in two hedge funds and trying to prop up the stock price of another drug company he led, Retrophin Inc. His release date is Oct. 11, 2022, prison records show.
Prosecutors said they still possess two other Shkreli assets, a Phoenixus stake and a Pablo Picasso engraving, that could be applied toward a $2.6 million judgment against him in a separate Manhattan civil case.
Brianne Murphy, a lawyer for Shkreli in the Manhattan case, declined to comment.
In January, Matsumoto rejected Shkreli’s request to be freed from prison, rejecting his claim that his deteriorating mental health justified “compassionate” release.
U.S. sells 'Pharma Bro' Shkreli's unique Wu-Tang Clan album
NEW YORK — The U.S. government said it sold imprisoned drug company executive Martin Shkreli’s one-of-a-kind album by Wu-Tang Clan to pay off the $7.36 million…
U.S. judge rejects Pharma Bro's objections to lifetime drug industry ban
Author of the article:
Reuters
Reuters
Jonathan Stempel
Publishing date:
Feb 04, 2022 • 2 days ago • 1 minute read •
Join the conversation
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017.
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017. Photo by CARLO ALLEGRI /REUTERS
Article content
NEW YORK — A U.S. judge on Friday rejected former pharmaceutical executive Martin Shkreli’s objections to being banned for life from the drug industry and having to repay $64.6 million after jacking up the price of a lifesaving drug.
Advertisement
Story continues below
Article content
Lawyers for Shkreli, 38, had argued that the ban was overbroad and violated his right to free speech under the U.S. Constitution’s First Amendment by barring him from publicly discussing the drug industry, even on a blog.
In imposing a permanent injunction, U.S. District Judge Denise Cote said Shkreli’s antitrust violations cost him that right when he intended to “influence the management or business” of a pharmaceutical company.
The Manhattan-based judge also said that requiring Shkreli to sell his shares in Phoenixus AG, the parent of Vyera Pharmaceuticals Inc, did not violate his due process rights after he used his position as its largest shareholder to orchestrate the antitrust violations.
Shkreli is serving a seven-year prison sentence in an unrelated securities fraud case.
Advertisement
Story continues below
Article content
His lawyers did not immediately respond to requests for comment.
In imposing the lifetime ban on Jan. 14, Cote found that Shkreli used “particularly heartless and coercive” tactics to maintain a monopoly over the drug Daraprim, which treats a parasitic infection, and keep generic rivals off the market.
Shkreli gained notoriety in 2015 and became known as “Pharma Bro” when he raised Daraprim’s price overnight to $750 per tablet from $17.50.
He had at the time been chief executive of Turing Pharmaceuticals, later renamed Vyera.
Cote’s rulings followed a non-jury trial in a case brought by the Federal Trade Commission and seven U.S. states.
Shkreli is eligible for release from prison on Nov. 7.
torontosun.com
Author of the article:
Reuters
Reuters
Jonathan Stempel
Publishing date:
Feb 04, 2022 • 2 days ago • 1 minute read •
Join the conversation
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017.
Former drug company executive Martin Shkreli exits U.S. District Court after being convicted of securities fraud in the Brooklyn borough of New York City, U.S., August 4, 2017. Photo by CARLO ALLEGRI /REUTERS
Article content
NEW YORK — A U.S. judge on Friday rejected former pharmaceutical executive Martin Shkreli’s objections to being banned for life from the drug industry and having to repay $64.6 million after jacking up the price of a lifesaving drug.
Advertisement
Story continues below
Article content
Lawyers for Shkreli, 38, had argued that the ban was overbroad and violated his right to free speech under the U.S. Constitution’s First Amendment by barring him from publicly discussing the drug industry, even on a blog.
In imposing a permanent injunction, U.S. District Judge Denise Cote said Shkreli’s antitrust violations cost him that right when he intended to “influence the management or business” of a pharmaceutical company.
The Manhattan-based judge also said that requiring Shkreli to sell his shares in Phoenixus AG, the parent of Vyera Pharmaceuticals Inc, did not violate his due process rights after he used his position as its largest shareholder to orchestrate the antitrust violations.
Shkreli is serving a seven-year prison sentence in an unrelated securities fraud case.
Advertisement
Story continues below
Article content
His lawyers did not immediately respond to requests for comment.
In imposing the lifetime ban on Jan. 14, Cote found that Shkreli used “particularly heartless and coercive” tactics to maintain a monopoly over the drug Daraprim, which treats a parasitic infection, and keep generic rivals off the market.
Shkreli gained notoriety in 2015 and became known as “Pharma Bro” when he raised Daraprim’s price overnight to $750 per tablet from $17.50.
He had at the time been chief executive of Turing Pharmaceuticals, later renamed Vyera.
Cote’s rulings followed a non-jury trial in a case brought by the Federal Trade Commission and seven U.S. states.
Shkreli is eligible for release from prison on Nov. 7.
U.S. judge rejects Pharma Bro's objections to lifetime drug industry ban
NEW YORK — A U.S. judge on Friday rejected former pharmaceutical executive Martin Shkreli’s objections to being banned for life from the drug industry and…
U.S. judge bans Pharma Bro from running public companies
Author of the article:Reuters
Reuters
Jody Godoy
Publishing date:Feb 23, 2022 • 13 hours ago • 1 minute read • Join the conversation
Former drug company executive Martin Shkreli arrives at U.S. District Court for the third day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 2, 2017.
Former drug company executive Martin Shkreli arrives at U.S. District Court for the third day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 2, 2017. PHOTO BY AMR ALFIKY /REUTERS
Article content
NEW YORK — A U.S. judge on Wednesday permanently barred former pharmaceutical executive Martin Shkreli from serving as an officer or director of publicly traded companies, and ordered him to pay a $1.39 million fine for violating securities law between 2009 and 2014.
Advertisement
STORY CONTINUES BELOW
Article content
U.S. District Judge Kiyo Matsumoto in Brooklyn issued her ruling in the U.S. Securities and Exchange Commission’s civil case alleging Shkreli defrauded investors in his hedge funds and raided his biotechnology company, Retrophin Inc, for funds to settle with investors.
Shkreli had proposed a 10-year officer and director ban, arguing that his seven-year prison sentence and $7.8 million in forfeiture and penalties in his related criminal case were sufficient punishment.
A lawyer for Shkreli did not immediately reply to a request for comment.
Shkreli became notorious and known as “Pharma Bro” in 2015, when he raised the price of the anti-parasitic drug Daraprim overnight to $750 per tablet from $17.50 while serving as chief executive of Turing Pharmaceuticals, later renamed Vyera Pharmaceuticals.
Advertisement
STORY CONTINUES BELOW
Article content
He was arrested that year on fraud and conspiracy charges connected to Retrophin and his MSMB Capital Management and MSMB Healthcare Management hedge funds.
In her decision, Matsumoto called Shkreli a “chaotic, dishonest, and untrustworthy corporate leader” who would likely violate the law again if allowed to run a public company.
Shkreli is serving his sentence at a low-security prison in Allenwood, Pennsylvania, and will be eligible for release in November.
Last month, a federal judge in Manhattan barred Shkreli from the drug industry for life and ordered him to pay $64.6 million.
That followed a nonjury trial where federal and state regulators claimed Shkreli tried to maintain an illegal monopoly over Daraprim and keep generic rivals off the market.
torontosun.com
Author of the article:Reuters
Reuters
Jody Godoy
Publishing date:Feb 23, 2022 • 13 hours ago • 1 minute read • Join the conversation
Former drug company executive Martin Shkreli arrives at U.S. District Court for the third day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 2, 2017.
Former drug company executive Martin Shkreli arrives at U.S. District Court for the third day of jury deliberations in his securities fraud trial in the Brooklyn borough of New York City, U.S., August 2, 2017. PHOTO BY AMR ALFIKY /REUTERS
Article content
NEW YORK — A U.S. judge on Wednesday permanently barred former pharmaceutical executive Martin Shkreli from serving as an officer or director of publicly traded companies, and ordered him to pay a $1.39 million fine for violating securities law between 2009 and 2014.
Advertisement
STORY CONTINUES BELOW
Article content
U.S. District Judge Kiyo Matsumoto in Brooklyn issued her ruling in the U.S. Securities and Exchange Commission’s civil case alleging Shkreli defrauded investors in his hedge funds and raided his biotechnology company, Retrophin Inc, for funds to settle with investors.
Shkreli had proposed a 10-year officer and director ban, arguing that his seven-year prison sentence and $7.8 million in forfeiture and penalties in his related criminal case were sufficient punishment.
A lawyer for Shkreli did not immediately reply to a request for comment.
Shkreli became notorious and known as “Pharma Bro” in 2015, when he raised the price of the anti-parasitic drug Daraprim overnight to $750 per tablet from $17.50 while serving as chief executive of Turing Pharmaceuticals, later renamed Vyera Pharmaceuticals.
Advertisement
STORY CONTINUES BELOW
Article content
He was arrested that year on fraud and conspiracy charges connected to Retrophin and his MSMB Capital Management and MSMB Healthcare Management hedge funds.
In her decision, Matsumoto called Shkreli a “chaotic, dishonest, and untrustworthy corporate leader” who would likely violate the law again if allowed to run a public company.
Shkreli is serving his sentence at a low-security prison in Allenwood, Pennsylvania, and will be eligible for release in November.
Last month, a federal judge in Manhattan barred Shkreli from the drug industry for life and ordered him to pay $64.6 million.
That followed a nonjury trial where federal and state regulators claimed Shkreli tried to maintain an illegal monopoly over Daraprim and keep generic rivals off the market.
U.S. judge bans Pharma Bro from running public companies
NEW YORK — A U.S. judge on Wednesday permanently barred former pharmaceutical executive Martin Shkreli from serving as an officer or director of publicly…
Ex-‘Pharma Bro’ Martin Shkreli now living in Queens on $2,500 a month
The former pharmaceutical CEO who served almost seven years in prison for securities fraud is consulting for a law firm
Author of the article:Bloomberg News
Bloomberg News
Erik Larson and Patricia Hurtado
Published May 30, 2023 • 2 minute read
Martin Shkreli, the former pharmaceutical chief executive officer who served almost seven years in prison for securities fraud, is earning $2,500-a-month consulting for a law firm and living with his sister in Queens, New York, according to the US Probation Office.
Shkreli, 40, has had a mostly “positive adjustment” since being released from prison last year and is currently employed by the Law Office of Christopher K. Johnston LLC, according to a probation report filed Tuesday in federal court in Brooklyn, New York.
The report didn’t elaborate on Shkreli’s duties or say how or when he got the job. Neither the law firm nor Shkreli’s attorney immediately responded to messages seeking comment.
When contacted by phone, Shkreli said: “I will only comment if you give me significant financial compensation.”
Shkreli is also employed by a software company he co-founded called Druglike, now named DL Software, where he denies having “any ownership or executive role,” according to the Probation Office. The report didn’t identify Shkreli’s role at the company or specify what salary, if any, he is receiving. It also said Shkreli has satisfied his restitution and forfeiture “and has no outstanding financial obligations with the court.”
The former Turing Pharmaceuticals CEO did have an initial delay in carrying out his mandatory community service of 20 hours a month, which resulted in a technical violation of his supervision, according to the filing. Shkreli blamed the delay on scheduling conflicts and mental health issues and has been in compliance since April 3.
Shkreli also completed his mandatory therapy appointments last year, the probation office said, but he will be “re-referred for mental health treatment” due to his “self-reported struggles.” The filing didn’t elaborate on what those struggles were.
Dubbed “the most hated man in America” after he raised the price of a potentially life-saving drug by 5,000%, Shkreli was convicted in 2017 of defrauding investors in two hedge funds. In May 2022, he was released four months early from a low-security federal prison in Allenwood, Pennsylvania, and transferred to a halfway house.
Shkreli was once a multimillionaire who adorned his walls with a Picasso, drank rare wines, owned an Enigma encryption machine used by the Nazis in World War II, letters by Charles Darwin and Ada Lovelace, the English mathematician celebrated as the first mechanical general purpose computer inventor, and famously bought the only copy of the Wu-Tang Clan’s Once Upon a Time in Shaolin. Those possessions were all later sold to cover his penalties and liabilities.
torontosun.com
The former pharmaceutical CEO who served almost seven years in prison for securities fraud is consulting for a law firm
Author of the article:Bloomberg News
Bloomberg News
Erik Larson and Patricia Hurtado
Published May 30, 2023 • 2 minute read
Martin Shkreli, the former pharmaceutical chief executive officer who served almost seven years in prison for securities fraud, is earning $2,500-a-month consulting for a law firm and living with his sister in Queens, New York, according to the US Probation Office.
Shkreli, 40, has had a mostly “positive adjustment” since being released from prison last year and is currently employed by the Law Office of Christopher K. Johnston LLC, according to a probation report filed Tuesday in federal court in Brooklyn, New York.
The report didn’t elaborate on Shkreli’s duties or say how or when he got the job. Neither the law firm nor Shkreli’s attorney immediately responded to messages seeking comment.
When contacted by phone, Shkreli said: “I will only comment if you give me significant financial compensation.”
Shkreli is also employed by a software company he co-founded called Druglike, now named DL Software, where he denies having “any ownership or executive role,” according to the Probation Office. The report didn’t identify Shkreli’s role at the company or specify what salary, if any, he is receiving. It also said Shkreli has satisfied his restitution and forfeiture “and has no outstanding financial obligations with the court.”
The former Turing Pharmaceuticals CEO did have an initial delay in carrying out his mandatory community service of 20 hours a month, which resulted in a technical violation of his supervision, according to the filing. Shkreli blamed the delay on scheduling conflicts and mental health issues and has been in compliance since April 3.
Shkreli also completed his mandatory therapy appointments last year, the probation office said, but he will be “re-referred for mental health treatment” due to his “self-reported struggles.” The filing didn’t elaborate on what those struggles were.
Dubbed “the most hated man in America” after he raised the price of a potentially life-saving drug by 5,000%, Shkreli was convicted in 2017 of defrauding investors in two hedge funds. In May 2022, he was released four months early from a low-security federal prison in Allenwood, Pennsylvania, and transferred to a halfway house.
Shkreli was once a multimillionaire who adorned his walls with a Picasso, drank rare wines, owned an Enigma encryption machine used by the Nazis in World War II, letters by Charles Darwin and Ada Lovelace, the English mathematician celebrated as the first mechanical general purpose computer inventor, and famously bought the only copy of the Wu-Tang Clan’s Once Upon a Time in Shaolin. Those possessions were all later sold to cover his penalties and liabilities.
Ex-‘Pharma Bro’ Martin Shkreli now living in Queens on $2,500 a month
The former pharmaceutical CEO who served almost seven years in prison for securities fraud is consulting for a law firm